In fact, absent expression of SMAD4 (a key transcription factor for TGF-β signaling) is an independent poor prognostic factor after curative surgery for Stage II/III CRC and CRC liver metastases [15,27,28,29]. The gene discussed is TGFB1; the disease is colorectal carcinoma.